Workflow
Treatment for obesity plateau population
icon
Search documents
Veru outlines 72-week Phase IIb PLATEAU study targeting obesity plateau population following FDA guidance (NASDAQ:VERU)
Seeking Alpha· 2025-12-17 17:01
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...